• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011

tetano

Editor, Senior Moderator
J Infect Dis. 2018 Jan 12. doi: 10.1093/infdis/jiy013. [Epub ahead of print]
[h=1]Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011.[/h] Rolfes MA[SUP]1[/SUP], Gross FL[SUP]1,[/SUP][SUP]2[/SUP], Flannery B[SUP]1[/SUP], Meyers AFA[SUP]3,[/SUP][SUP]4,[/SUP][SUP]5[/SUP], Luo M[SUP]3[/SUP], Bastien N[SUP]3[/SUP], Fowler RA[SUP]6[/SUP], Katz JM[SUP]1[/SUP], Levine MZ[SUP]1[/SUP], Kumar A[SUP]7[/SUP], Uyeki TM[SUP]1[/SUP]; Canadian Severe Influenza Study (CSIS) and the Randomized, Double-Blinded Controlled Trial Comparing High vs Standard Dose Oseltamivir in Severe, Influenza Infection in ICU (ROSII) Study Groups.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] The kinetics of the antibody response during severe influenza are not well documented.
[h=4]Methods:[/h] Critically ill patients with influenza A(H1N1)pdm09 virus infection, confirmed by RT-PCR or seroconversion (≥4-fold rise in titers), during 2009-2011 in Canada were prospectively studied. Antibody titers in serially collected sera were determined using hemagglutinin inhibition (HAI) and microneutralization assays. Average antibody curves were estimated using linear mixed effects models and compared by patient outcome, age, and corticosteroid treatment.
[h=4]Results:[/h] Of 47 patients with A(H1N1)pdm09 virus infection (median age 47 years), 59% had baseline HAI and 68% had baseline neutralizing titers <40. Antibody titers rose quickly after symptom onset and, by day 14, 83% of patients had HAI and 80% had neutralizing titers ≥40. Baseline HAI titers were significantly higher in patients who died compared with patients who survived; however, the antibody kinetics were similar by patient outcome and corticosteroid treatment. Geometric mean titers over time in older patients were lower compared with younger patients.
[h=4]Conclusions:[/h] Critically ill patients with influenza A(H1N1)pdm09 virus infection had strong HAI and neutralizing antibody responses during their illness. Antibody kinetics differed by age but were not associated with patient outcome.


[h=4]KEYWORDS:[/h] Influenza; critical illness; humoral immunity

PMID: 29342251 DOI: 10.1093/infdis/jiy013
 
Back
Top